Suppr超能文献

相似文献

1
Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study.
J Adv Pharm Technol Res. 2022 Apr-Jun;13(2):128-132. doi: 10.4103/japtr.japtr_325_21. Epub 2022 Apr 7.
2
Furosemide ethanol-free oral solutions for paediatric use: formulation, HPLC method and stability study.
Eur J Hosp Pharm. 2018 May;25(3):144-149. doi: 10.1136/ejhpharm-2017-001264. Epub 2017 Aug 2.
3
Stability of Furosemide 5 mg/mL in Polypropylene Syringes.
Int J Pharm Compd. 2019 Sep-Oct;23(5):414-417.
4
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.
5
Design and stability study of an oral solution of amlodipine besylate for pediatric patients.
Eur J Pharm Sci. 2016 Sep 20;92:220-3. doi: 10.1016/j.ejps.2016.05.019. Epub 2016 May 20.
7
Permeation studies through porcine small intestine of furosemide solutions for personalised paediatric administration.
Int J Pharm. 2014 Nov 20;475(1-2):208-13. doi: 10.1016/j.ijpharm.2014.08.059. Epub 2014 Aug 29.
10
Stabilisation of amorphous furosemide increases the oral drug bioavailability in rats.
Int J Pharm. 2015 Jul 25;490(1-2):334-40. doi: 10.1016/j.ijpharm.2015.05.063. Epub 2015 May 27.

引用本文的文献

1
Stability Assessment of Furosemide Oral Suspension in Hospital Extemporaneous Preparations.
Pharmaceuticals (Basel). 2025 Jun 20;18(7):937. doi: 10.3390/ph18070937.

本文引用的文献

1
Current Status of Pediatric Formulations for Chronic and Acute Children' Diseases: Applications and Future Perspectives.
Medeni Med J. 2021;36(2):152-162. doi: 10.5222/MMJ.2021.78476. Epub 2021 Jun 18.
2
Excipients in the Paediatric Population: A Review.
Pharmaceutics. 2021 Mar 13;13(3):387. doi: 10.3390/pharmaceutics13030387.
3
ey Potentially nappropriate rugs in Pediatrics: The KIDs List.
J Pediatr Pharmacol Ther. 2020;25(3):175-191. doi: 10.5863/1551-6776-25.3.175.
4
Furosemide ethanol-free oral solutions for paediatric use: formulation, HPLC method and stability study.
Eur J Hosp Pharm. 2018 May;25(3):144-149. doi: 10.1136/ejhpharm-2017-001264. Epub 2017 Aug 2.
6
[Osmolality of oral liquid dosage forms to be administered to newborns in a hospital].
Farm Hosp. 2007 Sep-Oct;31(5):311-4. doi: 10.1016/s1130-6343(07)75395-3.
7
Unlicensed and off-label drug use: issues and recommendations.
Paediatr Drugs. 2002;4(6):353-9. doi: 10.2165/00128072-200204060-00002.
9
The effect of paraben preservatives on albumin binding of bilirubin.
J Pediatr. 1976 Sep;89(3):475-8. doi: 10.1016/s0022-3476(76)80557-4.
10
Stability of furosemide in aqueous systems.
J Pharm Sci. 1978 Jun;67(6):808-11. doi: 10.1002/jps.2600670621.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验